268 related articles for article (PubMed ID: 1331757)
1. Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells.
Gucker S; Bidlack JM
Mol Pharmacol; 1992 Oct; 42(4):656-65. PubMed ID: 1331757
[TBL] [Abstract][Full Text] [Related]
2. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic D-Ala,2 D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma x glioma NG108-15 hybrid cells.
Law PY; Hom DS; Loh HH
J Pharmacol Exp Ther; 1991 Feb; 256(2):710-6. PubMed ID: 1847209
[TBL] [Abstract][Full Text] [Related]
4. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
Roerig SC; Loh HH; Law PY
Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
[TBL] [Abstract][Full Text] [Related]
5. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
Law PY; Hom DS; Loh HH
Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
[TBL] [Abstract][Full Text] [Related]
6. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
7. Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
Belcheva MM; Barg J; Gloeckner C; Gao XM; Chuang DM; Coscia CJ
Mol Pharmacol; 1992 Sep; 42(3):445-52. PubMed ID: 1328845
[TBL] [Abstract][Full Text] [Related]
8. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
[TBL] [Abstract][Full Text] [Related]
9. Desensitization and resensitization of delta-opioid receptor-mediated Ca2+ channel inhibition in NG108-15 cells.
Morikawa H; Fukuda K; Mima H; Shoda T; Kato S; Mori K
Br J Pharmacol; 1998 Mar; 123(6):1111-8. PubMed ID: 9559894
[TBL] [Abstract][Full Text] [Related]
10. Role of protein kinase C subtypes alpha and delta in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes.
Chen CC; Chang J; Chen WC
Mol Pharmacol; 1995 Jul; 48(1):39-47. PubMed ID: 7623773
[TBL] [Abstract][Full Text] [Related]
11. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.
Jin W; Lee NM; Loh HH; Thayer SA
Mol Pharmacol; 1992 Dec; 42(6):1083-9. PubMed ID: 1336113
[TBL] [Abstract][Full Text] [Related]
12. Activation of protein kinase C rapidly down-regulates naloxone-resistant receptors for beta-endorphin on U937 cells.
Shahabi NA; Sharp BM
J Pharmacol Exp Ther; 1993 Jan; 264(1):276-81. PubMed ID: 8380863
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone.
Belcheva MM; Barg J; McHale RJ; Gao XM; Chuang DM; Coscia CJ
J Pharmacol Exp Ther; 1991 Oct; 259(1):302-9. PubMed ID: 1656025
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
15. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
Law PY; Loh HH
Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
[TBL] [Abstract][Full Text] [Related]
16. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
Costa T; Wüster M; Gramsch C; Herz A
Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735
[TBL] [Abstract][Full Text] [Related]
17. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 5-hydroxytryptamine-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine cultured tracheal smooth muscle cells by phorbol ester.
Yang CM; Fen LW; Tsao HL; Chiu CT
Br J Pharmacol; 1997 Jul; 121(5):853-60. PubMed ID: 9222540
[TBL] [Abstract][Full Text] [Related]
19. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
Prather PL; Loh HH; Law PY
Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
[TBL] [Abstract][Full Text] [Related]
20. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.
Bergsbaken CL; Sommers SL; Law PY
J Pharmacol Exp Ther; 1993 Mar; 264(3):1474-83. PubMed ID: 7680718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
